Administration of Brincidofovir and Convalescent Plasma in a Patient with Ebola Virus Disease

Diana F Florescu, Andre C Kalil, Angela L Hewlett, Amy J. Schuh, Ute Stroher, Timothy M. Uyeki, Philip W. Smith

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

From 2014 to May 2015, >26 000 Ebola virus disease (EVD) cases were reported from West Africa. We present a patient with EVD who received brincidofovir and convalescent plasma. The relative contributions of supportive care, investigational therapies, and patient's immune-response on survival could not be determined. Randomized trials are needed.

Original languageEnglish (US)
Pages (from-to)969-973
Number of pages5
JournalClinical Infectious Diseases
Volume61
Issue number6
DOIs
StatePublished - Jun 8 2015

Fingerprint

Ebola Hemorrhagic Fever
Investigational Therapies
Western Africa
Survival
cidofovir hexadecyloxypropyl ester

Keywords

  • Ebola
  • investigational therapies
  • trials

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Administration of Brincidofovir and Convalescent Plasma in a Patient with Ebola Virus Disease. / Florescu, Diana F; Kalil, Andre C; Hewlett, Angela L; Schuh, Amy J.; Stroher, Ute; Uyeki, Timothy M.; Smith, Philip W.

In: Clinical Infectious Diseases, Vol. 61, No. 6, 08.06.2015, p. 969-973.

Research output: Contribution to journalArticle

@article{45ca6a78ca5849bcaa50940bfe0b2465,
title = "Administration of Brincidofovir and Convalescent Plasma in a Patient with Ebola Virus Disease",
abstract = "From 2014 to May 2015, >26 000 Ebola virus disease (EVD) cases were reported from West Africa. We present a patient with EVD who received brincidofovir and convalescent plasma. The relative contributions of supportive care, investigational therapies, and patient's immune-response on survival could not be determined. Randomized trials are needed.",
keywords = "Ebola, investigational therapies, trials",
author = "Florescu, {Diana F} and Kalil, {Andre C} and Hewlett, {Angela L} and Schuh, {Amy J.} and Ute Stroher and Uyeki, {Timothy M.} and Smith, {Philip W.}",
year = "2015",
month = "6",
day = "8",
doi = "10.1093/cid/civ395",
language = "English (US)",
volume = "61",
pages = "969--973",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Administration of Brincidofovir and Convalescent Plasma in a Patient with Ebola Virus Disease

AU - Florescu, Diana F

AU - Kalil, Andre C

AU - Hewlett, Angela L

AU - Schuh, Amy J.

AU - Stroher, Ute

AU - Uyeki, Timothy M.

AU - Smith, Philip W.

PY - 2015/6/8

Y1 - 2015/6/8

N2 - From 2014 to May 2015, >26 000 Ebola virus disease (EVD) cases were reported from West Africa. We present a patient with EVD who received brincidofovir and convalescent plasma. The relative contributions of supportive care, investigational therapies, and patient's immune-response on survival could not be determined. Randomized trials are needed.

AB - From 2014 to May 2015, >26 000 Ebola virus disease (EVD) cases were reported from West Africa. We present a patient with EVD who received brincidofovir and convalescent plasma. The relative contributions of supportive care, investigational therapies, and patient's immune-response on survival could not be determined. Randomized trials are needed.

KW - Ebola

KW - investigational therapies

KW - trials

UR - http://www.scopus.com/inward/record.url?scp=84940659400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940659400&partnerID=8YFLogxK

U2 - 10.1093/cid/civ395

DO - 10.1093/cid/civ395

M3 - Article

C2 - 25991468

AN - SCOPUS:84940659400

VL - 61

SP - 969

EP - 973

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 6

ER -